CLINICAL_TRIALS
trial_result
· 2016-06-20
Clinical Trial Update: Bosutinib in Adult Patients With Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial results for bosutinib in adults with recurrent glioblastoma have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2016-06-20